Industry News

Future Forum Announced the Winners of 2021 Future Science Prize: Kwok-Yung Yuen, Joseph Sriyal Malik Peiris, Jie Zhang, Simon Sze

BEIJING, Sept. 13, 2021 /PRNewswire/ -- Future Science Prize announced the winners of 2021 inBeijing on September 12th. Prof. Kwok-Yung Yuen and Prof. Joseph Sriyal Malik Peiris won the Prize in life sciences for their discoveries of SARS-CoV-1 as the causative agent for the global SARS outbreak ...

2021-09-13 19:03 2703

Eventus wins FOW Asia Capital Markets Award for market surveillance excellence

AUSTIN, Texas, Sept. 13, 2021 /PRNewswire/ -- Eventus Systems, Inc., a leading global provider of multi-asset class trade surveillance and market risk solutions, has won the FOW Asia Capital Markets Award for Best New Product – Market Surveillance. The award is the second honor the firm has earne...

2021-09-13 19:00 1518

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...

2021-09-13 19:00 6676

CooTek's Enhanced Profitability in Online Literature and Mobile Games Are Coming Along

SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- CooTek (Cayman) Inc. (NYSE: CTK) ("CooTek" or the "Company"), a global mobile internet company, has achieved diversification of revenue and enhancement in profitability through the innovations in mobile gaming and original IP content, thanks to its improve...

2021-09-13 18:30 4519

FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke

STATE COLLEGE, Pa., Sept. 13, 2021 /PRNewswire/ -- * FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell's first-in-human clinical studies * Drug substance manufacturing will be carried out in...

2021-09-13 18:00 2221

Ready-to-Ride Style: Yadea Celebrates the Pursuit of Beauty as In-Person Fashion Shows Return

MUNICH, Sept. 13, 2021 /PRNewswire/ -- As the world gradually returns to a "new normal", September will see the return of in-person fashion shows for Autumn/Winter 2021. As design and fashion once again become hot topics in the global arena, Yadea, the world's leading electric two-wheeler brand, ...

2021-09-13 17:54 2425

Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets

SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest" or the "Company") announced today two separate definitive agreements ("Agreements") withProvidence Therapeutics Holdings Inc.

2021-09-13 17:00 5290

Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors

HOUSTON and SINGAPORE, Sept. 13, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the U.S. Food and Drug Administration (FDA) has approved the initiation of a Phas...

2021-09-13 17:00 2013

Avia Solutions Group to enter into strategic partnership with Certares through a €300 million investment in the Group

LONDON, Sept. 13, 2021 /PRNewswire/ -- Avia Solutions Group is pleased to announce it has entered into a strategic partnership with Certares Management LLC ("Certares"), a leading US-based investment specialist dedicated to the travel, tourism and hospitality sectors, in which Certares will provi...

2021-09-13 17:00 5345

Lioner Appoints Another Top Industry Veteran as Partner

* Andrew Chan appointed as Partner at Lioner * Dedicates to sharpen the company's focus and navigates opportunities in Asia and across other regions with its pioneer 3-in-1 solutions consortium * Anticipates more key industry stalwarts and talents to join to elevate the talent pool at Lioner...

2021-09-13 16:30 4514

Yum China Strengthens its Commitment to Promoting Balanced Diets and Healthy Lifestyles

SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced the launch of a new campaign to promote balanced diets by offering customers more fruit and vegetable options. The campaign will launch simultaneously onSeptember ...

2021-09-13 16:30 3503

OneConnect Accelerates Strategic Growth with New "One Body and Two Wings" Five-year Strategy

SHENZHEN, China, Sept. 13, 2021 /PRNewswire/ -- On September 10, OneConnect Financial Technology Co., Ltd. (NYSE: OCFT) ("OneConnect"), a leading technology-as-a-service platform for financial institutions and associate of Ping An Group, hosted an open day event with the theme, "Technology Create...

2021-09-13 16:20 9000

Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions

AI-based mobile medical applications to diagnose and manage respiratory diseases can reduce costs by eliminating the need for regular medical tests, finds Frost & Sullivan SANTA CLARA, Calif., Sept. 13, 2021 /PRNewswire/ -- The COVID-19 outbreak has inflated the demand for smart and digitally co...

2021-09-13 16:02 2017

CPOPC Holds A Writing Competition on Smallholder's Topic

JAKARTA, Indonesia, Sept. 13, 2021 /PRNewswire/ -- A short story competition with the theme "smallholders and oil palm plantation" is now open for entries. This competition organized by the Council of Palm Oil Producing Countries (CPOPC) engages the communities and families living near or within ...

2021-09-13 16:00 2359

Joy Spreader's Interim Results Press Conference: Data Accumulation, Data Analytics and Algorithm Modeling Form the Core of the Firm's Strengths

BEIJING, Sept. 13, 2021 /PRNewswire/ -- According to the interim financial report for 2021 recently released by Joy Spreader Group Inc. (HKG:6988, "the Group", "Joy Spreader"), a leading marketing technology company listed inHong Kong, the Group's spend on research and development (R&D) rose to H...

2021-09-13 15:59 3383

Forrester: 24% Of Indian Brands Delivered Poorer Customer Experiences In 2021

NEW DELHI, Sept. 13, 2021 /PRNewswire/ -- According to Forrester's  (Nasdaq: FORR) 2021 India Customer Experience Index (CX Index™) , only four out of 29 brands managed to significantl...

2021-09-13 15:46 9507

UBTECH Panda Robot Makes Global Debut

SHENZHEN, China, Sept. 13, 2021 /PRNewswire/ -- UBTECH Panda Robot recently made its global debut at the 2021 World Robot Conference inBeijing, paving the way for its appearance at the China Pavilion at Expo 2020 Dubai which starts next month. The 1.3-meter tall, 63-kg robot was customized for t...

2021-09-13 15:39 3991

Xinhua Silk Road: 2021 Silk Road Maritime Brand Influence Parallel Forum held in Xiamen

BEIJING, Sept. 13, 2021 /PRNewswire/ -- The Brand Influence Parallel Forum of the 2021Silk Road Maritime International Cooperation Forum was held onlast Thursday in Xiamen City of southeast China's Fujian province, aiming to strengthen international economic and trade...

2021-09-13 15:03 3539

Markel opens Paris branch to support small and medium-sized enterprises in the French market

LONDON, Sept. 13, 2021 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that it has opened a new branch office inParis to support small and medium-sized enterprises (SMEs) in the French market. The move is part of a longstanding strategy to further expand and scale the company's gl...

2021-09-13 15:00 8689

Harbour BioMed Announces Phase I Study Positive Results on Next-Generation Anti-CTLA-4 Antibody HBM4003

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 13, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced positive results from its phase I dose escalation clinical trial of HBM4003 in solid tumors in Australia (the "phase I study"). The clinical data abstract has...

2021-09-13 14:34 3300

Week's Top Stories